Bikorimana, Jean Pierre
El-Hachem, Nehme
Abusarah, Jamilah
Gonçalves, Marina Pereira
Farah, Roudy
Mandl, Gabrielle A.
Talbot, Sebastien
Beaudoin, Simon
Stanga, Daniela
Plouffe, Sebastien
Rafei, Moutih
Funding for this research was provided by:
Canadian Institute of Health Research (PJT-186233)
Defence Therapeutics (RB080035)
Article History
Received: 11 February 2024
Accepted: 22 May 2024
First Online: 3 June 2024
Declarations
:
: The animal protocol #22–065 was approved by the Animal Care Committee (CDEA) of Université de Montréal.
: Not applicable.
: Nehme El-Hachem is an employee of Bio2Cure Inc. and declares competing financial interest. Simon Beaudoin, Daniela Stanga and Sebastien Plouffe are employees of Defence Therapeutics Inc. and declare competing financial interest. Moutih Rafei is a board member of Defence Therapeutics.